Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids01:24

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids

206
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
206
Hallucinogens and Psychedelics01:27

Hallucinogens and Psychedelics

179
Hallucinogens are psychoactive substances that profoundly alter perceptual experiences, generating unreal visual and sensory images. Often referred to as psychedelic drugs — a term derived from the Greek words "psyche" (mind) and "delos" (revealing) — these substances include marijuana and lysergic acid diethylamide (LSD), among others. These drugs vary in intensity and effects.
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
179
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

69
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
69
CNS Depressants: Alcohol and Nicotine01:27

CNS Depressants: Alcohol and Nicotine

220
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
220
Stimulants01:29

Stimulants

220
Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
220
Substance Use Disorders Affecting Sleep01:24

Substance Use Disorders Affecting Sleep

174
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
174

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sex differences in stress responding in a randomized, placebo-controlled clinical trial of progesterone in cannabis use disorder.

Psychopharmacology·2026
Same author

Contextualizing the Future <i>DSM</i>: Cross-Cultural, Developmental, and Multi-Informant Considerations.

The American journal of psychiatry·2026
Same author

Relationships between cannabis use and mental disorders: assessing the coherence of evidence from studies with different methodologies.

The lancet. Psychiatry·2026
Same author

An improved method for quantification of cannabidiol, Δ<sup>9</sup>-tetrahydrocannabinol, and their metabolites in human plasma and urine.

Journal of pharmaceutical and biomedical analysis·2026
Same author

Violence and threat exposure is associated with frontostriatal alterations during risky decision-making in children with co-morbid ADHD and disruptive behavior disorders.

Frontiers in psychiatry·2026
Same author

Medication Samples and Smoking Cessation Among Adults: A Randomized Clinical Trial.

JAMA network open·2026

Related Experiment Video

Updated: Jul 11, 2025

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study
07:30

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study

Published on: August 18, 2020

6.7K

CANNABIS USE AND THE DEVELOPING BRAIN: HIGHS AND LOWS.

Yasmin L Hurd1, Jacqueline-Marie N Ferland1, Yoko Nomura1,2,3,4

  • 1Departments of Neuroscience and Psychiatry, Addiction Institute of Mount Sinai, Icahn School of Medicine at Mount Sinai, New York, NY, United States.

Frontiers for Young Minds
|November 10, 2023
PubMed
Summary

Cannabis (cannabinoids) use during pregnancy and adolescence can negatively impact brain development, affecting emotional control. This overview discusses these effects and prevention strategies for young people.

More Related Videos

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes
05:13

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes

Published on: February 28, 2025

214
Development of a Preclinical Inhalation Model to Test Vaporized Cannabis Distillates
06:09

Development of a Preclinical Inhalation Model to Test Vaporized Cannabis Distillates

Published on: May 30, 2025

141

Related Experiment Videos

Last Updated: Jul 11, 2025

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study
07:30

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study

Published on: August 18, 2020

6.7K
Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes
05:13

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes

Published on: February 28, 2025

214
Development of a Preclinical Inhalation Model to Test Vaporized Cannabis Distillates
06:09

Development of a Preclinical Inhalation Model to Test Vaporized Cannabis Distillates

Published on: May 30, 2025

141

Area of Science:

  • Neuroscience
  • Developmental Biology
  • Pharmacology

Background:

  • Cannabis, a plant with a long history of human use, contains cannabinoids.
  • Cannabinoids interact with the human body through various mechanisms.
  • The developing brain, particularly during pregnancy and adolescence, is sensitive to external influences.

Purpose of the Study:

  • To provide an overview of the effects of cannabinoids on the developing brain.
  • To examine the impact of cannabis use during prenatal development and adolescence.
  • To offer information on preventing or minimizing negative neurological consequences.

Main Methods:

  • Literature review of existing research on cannabinoid effects.
  • Analysis of studies focusing on brain development in relation to cannabis exposure.
  • Synthesis of information on neurobiological and functional outcomes.

Main Results:

  • Cannabis use during critical developmental periods can lead to lasting alterations in brain structure and function.
  • Adolescent brain development, including emotional regulation systems, is particularly vulnerable to cannabinoid exposure.
  • Prenatal exposure to cannabinoids may also result in significant neurodevelopmental changes.

Conclusions:

  • Cannabinoid exposure during development poses risks to long-term brain health and function.
  • Understanding these risks is crucial for public health initiatives targeting youth and pregnant individuals.
  • Preventative measures and education are essential to mitigate the adverse effects of cannabis on the developing brain.